Skip to main content
915 TLDR
Health
1 read

California Faces Surge in Wild Mushroom Poisoning Incidents

KTSM••Meg Hilling
Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KTSM

Read Original

AI Summary

Since November 2025, California has reported 50 cases of wild mushroom poisonings, with four fatalities linked to these incidents. The California Department of Public Health (CDPH) is raising awareness about the dangers of foraging for wild mushrooms, which can be toxic and potentially lethal. This alarming trend highlights the need for caution and education regarding mushroom identification and consumption. Residents are urged to avoid picking and consuming wild mushrooms unless they are certain of their safety.

Key Details: • 50 documented cases of mushroom poisoning since November 2025 • 4 fatalities reported due to wild mushroom consumption • Public urged to exercise caution when foraging for mushrooms

health safety public-health mushroom-poisoning

People & Organizations

CaliforniaCalifornia Department of Public Health

Related Articles

KVIA•Jun 24

France Confirms First Ebola Case Linked to DRC Humanitarian Mission

A patient in France has tested positive for Ebola after returning from a humanitarian trip to the Democratic Republic of the Congo (DRC), marking the first case reported in France and outside Africa during the ongoing outbreak. The rare Bundibugyo strain of the virus has led to over 1,000 confirmed cases and at least 267 deaths in DRC. The patient is currently stable and was quickly admitted to a specialized facility where strict isolation measures were implemented. Health authorities are conducting an epidemiological investigation to trace contacts, with those exposed undergoing a 21-day home isolation. The risk to the general European population remains assessed as very low.

Health
1 min read
KTSM•Jun 24

White House Addresses Rumors on Trump's Access to Eli Lilly's Obesity Drug

The White House has clarified that speculation regarding former President Donald Trump's access to the experimental obesity drug retatrutide, produced by Eli Lilly, is unfounded. Although the drug is not yet approved by the FDA, it can be accessed through a compassionate use program for patients with life-threatening conditions. This clarification is significant as it highlights the ongoing discussions around drug access and approval processes, particularly for high-profile individuals. The compassionate use program allows for limited access to unapproved treatments, but it is not indicative of broader availability.

Health
1 min read
KTSM•Jun 24

White House Denies Trump Received Experimental Obesity Drug Access

The White House has dismissed rumors suggesting that former President Donald Trump was granted access to the experimental obesity drug retatrutide, produced by Eli Lilly, under a compassionate use program. This program typically allows patients with life-threatening conditions to access unapproved treatments. While the drug is not yet FDA-approved, it has been made available to select individuals under specific circumstances. The clarification from the White House highlights ongoing discussions around drug access and the implications of compassionate use policies.

Health
1 min read
KTSM•Jun 24

El Paso Welcomes Its First Dedicated Burn Center at UMC

University Medical Center of El Paso has launched the area's inaugural dedicated burn center, aimed at providing specialized care for burn victims. This facility is led by Dr. Philip Fidler, a nationally recognized expert in trauma and burn treatment. The establishment of this center is significant for the community, as it addresses a critical need for advanced burn care in the region. The center is expected to enhance recovery outcomes for patients suffering from severe burns and injuries, marking a major advancement in local healthcare resources.

Health
1 min read